Meeting II

January 29–30, 2001

The Foundry Building

1055 Thomas Jefferson Street, NW

Washington, DC

Meeting Objectives

  • Review several completed studies of anthrax vaccine safety and efficacy

  • Evaluate knowledge of vaccine components

  • Define needs for additional information gathering

  • Plan future meetings

Agenda

Monday, January 29, 2001

12:00 p.m.

Open Session

A review of some of the studies of the anthrax vaccine

12:00

The CDC Observational Study

Dr. Juli Clifford, Center for Biologics Evaluation and Research, FDA

12:30

Components of the Anthrax Vaccine Absorbed and Contrast with Merck Vaccine

Dr. Robert Myers, BioPort Corporation

1:00

Working lunch

1:30

Field Evaluation of a Human Anthrax Vaccine

Dr. Stanley Plotkin

2:00

Ft. Detrick Multi-Dose, Multi-Vaccine Safety Studies

LTC Phillip Pittman, U.S. Army Medical Research Institute of Infectious Diseases

2:30

Ft. Detrick Special Immunization Program

LTC Phillip Pittman



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement